Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Difterie-Tetanus-Kinkhoest (DTP) vaccin

Generic name
Difterie-Tetanus-Kinkhoest (DTP) vaccin
Brand name
ATC Code
J07AJ52

Pharmacokinetics in children

Evaluation of pharmacokinetic properties is not required for vaccines.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

Passive protection against whooping cough (pertussis)
  • Intramuscular
    • 0 years up to 1 year
      [1]
      • BE AWARE: MATERNAL ADMINISTRATION 0.5 ml/dose, once only.
Booster vaccination for diphtheria, whooping cough, tetanus
  • Intramuscular
    • ≥ 4 years
      [1]
      • 0.5 ml/dose, once only.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects in children

For children aged 4 - 8 years: (n = 839) (SmPC)

Upper respiratory tract infection, anorexia, irritability, somnolence, headache, difficulty concentrating, conjunctivitis, diarrhea, vomiting, gastrointestinal
disorders, rash, injection site reactions (such as redness and / or swelling), pain on the injection site, fatigue. pyrexia (fever ≥ 37.5 ° C including fever> 39.0 ° C)
extensive swelling of the vaccinated limb (sometimes including the adjacent joint), other injection site reactions (such as induration), pain.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Reference

  1. GlaxoSmithKline BV, SmPC Boostrix (RVG 35121) 20-05-2019, www.geneesmiddeleninformatiebank.nl

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes